Cardiome's Cardiome International AG granted Algorithm rights to commercialize IV Brinavess vernakalant for atrial fibrillation (AF) in the Middle East and North Africa

Cardiome Pharma Corp.

Canada / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Algorithm S.A.L.

Lebanon / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced